cureAssess (Q7370843)
From MaRDI portal
!
This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use the normal view instead:
Assessing Cure Model Appropriateness for Survival Data
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | cureAssess |
Assessing Cure Model Appropriateness for Survival Data |
Statements
Assesses whether cure models are appropriate for right-censored survival data, where a fraction of subjects may never experience the event of interest. Implements a two-stage workflow combining Kaplan-Meier visualization and comparison of parametric cure and non-cure models by the Akaike information criterion with formal diagnostics for sufficient follow-up and for the presence of a cured fraction. The diagnostics include the statistics of Maller and Zhou (1992) <doi:10.1093/biomet/79.4.731> and Maller and Zhou (1994) <doi:10.1080/01621459.1994.10476889>, the test of Shen (2000) <doi:10.1016/S0167-7152(00)00063-8>, and the ratio estimation of censored uncured subjects ('RECeUS') method of Selukar and Othus (2023) <doi:10.1002/sim.9610>.
0 references
14 September 2026
0 references
Durbadal Ghosh
0 references
